This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by University of Oslo.
Recruitment status was:  Active, not recruiting
Information provided by:
University of Oslo Identifier:
First received: September 13, 2005
Last updated: September 7, 2006
Last verified: September 2006
The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

Condition Intervention Phase
Magnetic Resonance Imaging, Intestine Small, Crohn Disease. Procedure: MRI of the small bowel Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: MRI of the Small Bowel. Comparison of Different Techniques and Contrast.

Resource links provided by NLM:

Further study details as provided by University of Oslo:

Estimated Enrollment: 40
Study Start Date: November 2004
Estimated Study Completion Date: June 2005

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • above 18 years
  • known Crohns disease or strong suspicion.
  • need of a small bowel examination

Exclusion Criteria:

  • pregnant
  • electrolyte disturbances.
  • Any MRI contraindications.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00204165

Ulleval Universitets sykehus
Kirkeveien 166, Oslo, Norway, 0407
Sponsors and Collaborators
University of Oslo
Study Director: Nils-Einar Kløw, Prof. MD Ulleval Universitetssykehus
  More Information Identifier: NCT00204165     History of Changes
Other Study ID Numbers: 431-04150
Study First Received: September 13, 2005
Last Updated: September 7, 2006

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases processed this record on June 23, 2017